Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors Grant US-11464774-B2 United States of America 11 Oct 2022
Method for treating cancer using a combination of Chk1 and ATR inhibitors Grant US-11179394-B2 United States of America 23 Nov 2021
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase Grant US-10745420-B2 United States of America 18 Aug 2020
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase Application US-10421765-B2 United States of America 24 Sep 2019
Heterocyclic inhibitors of ATR kinase Application US-10392376-B2 United States of America 27 Aug 2019
Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use Grant US-10301324-B2 United States of America 28 May 2019
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors Grant US-10196405-B2 United States of America 05 Feb 2019
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors Grant US-9981989-B2 United States of America 29 May 2018
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors Grant US-9663535-B2 United States of America 30 May 2017